send to a friend by email

PHARMACARE achieves net income of $1.64 million in 9M 2013

2013-11-03

According to Dar Al-Shifa Pharmaceuticals Company (PHARMACARE)’s data for the first nine months of the year, net profit after taxes reached 1,638,596 USD, PHARMACARE was listed on the PEX on April 23^rd, 2012, and income for the prior similar reporting period has not been disclosed. Total assets of the company reached 35,385,469 USD as of September 30^th, 2013, compared to total assets of 29,876,871 USD as of December 31^st, 2012, a net increase of 18.4%. Total liabilities of the company reached 15,306,643 USD as of September 30^th, 2013, compared to total liabilities of 10,932,921 USD as of December 31^st, 2012, a net increase of 40.0%. Net ownership equity of the company reached 20,078,826 USD as of September 30^th, 2013, compared with net ownership equity of 18,943,950 USD as of December 31^st, 2012, a net increase of 6.0 in the first nine months.